Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Carter SK (1984) Adjuvant chemotherapy in osteogenic sarcoma: The triumph that isn’t? J Clin Oncol 2(3): 147–148
2. Cortes EP, Holland JF, Wang JJ, Glidewell O (1975) Adriamycin (NSC-123127), in 87 patients with osteogenic sarcoma. Cancer Chemother Rep 6: 305–313
3. Cortes EP, Necheles TF, Holland JF, et al (1979) Adriamycin (ADR) alone vs ADR and high-dose methotrexate-citrovorum factor rescue (HDM-CFR) ad adjuvant to operable primary osteosarcoma. A randomized study by Cancer and Leukemia Group B (CALGB). Proc Am Assoc Cancer Res 20: 412
4. Edmonson JH, Green SJ, Ivins JC, et al (1984) A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2(3): 152–156
5. Ettinger LJ, Douglass HO, Highby DJ, et al. (1981) Adjuvant adriamycin (Adr) and cis-diammine-dichloroplatinum (cis-platinum) in primary costesarcoma. Cancer 47: 248–254
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumors and Related Conditions;Rockwood and Matsen's the Shoulder;2017
2. Chemotherapy;Pediatric Oncology;2016-09-22
3. The role of neoadjuvant chemotherapy in children with malignant solid tumors;Seminars in Pediatric Surgery;2012-02
4. Chemotherapy;Pediatric Oncology;2010
5. Tumors and Related Conditions;Rockwood and Matsen’s The Shoulder;2009